Developer docs
API playgroundTry for free, no card

Search company profiles

LifeX

Full company profile

uuid000392j

Namestring
LifeX
Legal namestring
LifeX Global
Websiteurl
lifexglobal.com
Company typeenum
Private
Founded yearint
2017
Descriptiontext

LifeX Global (operating as LifeX, and designated the Life Science Greenhouse for Western Pennsylvania by PA DCED) is a Pittsburgh-based, privately held life science startup support platform founded in 2017. It operates a four-program continuum — Accelerator, Launchpad, Catalyst, and Ventures — augmented by LifeX Connect for talent matching, designed to move early-stage life science ventures from translational research through Series A funding. The Accelerator is a three-month virtual cohort program offered at no cost and with no equity taken, structured around 25+ interactive sessions and a curated network of 70+ domain experts, investors, and mentors. Launchpad provides milestone-driven, customized project support for startups approaching pilots or fundraising, priced on a deliverable-based fee/equity structure. Catalyst embeds seasoned executives into portfolio companies to drive strategy and execution, typically feeding the Ventures investment pipeline. Ventures deploys pre-seed through Series A capital in medical devices, health-tech, biotech, pharmaceuticals, and digital health, targeting milestone-based inflection points.

LifeX's business model mixes non-dilutive capital (a $2M U.S. EDA Build to Scale grant awarded in November 2023, plus Hillman Foundation and PA DCED support), fee/equity compensation from Launchpad, and equity ownership in portfolio companies through Ventures. Go-to-market is sales-led and referral-driven: companies enter via direct application, university partnerships (University of Pittsburgh, Carnegie Mellon, University of Maryland), or ecosystem referrals (PLSA, Women in Bio Pittsburgh, UPMC Enterprises), then flow through the continuum via internal handoffs. The organization is headquartered at 218 Oakland Ave, Pittsburgh, with a stated 1-10 person core team and a much larger 70+ expert network, serving a national founder base through virtual cohorts with an in-person Pittsburgh bootcamp. Its portfolio spans digital health, therapeutics, medical devices, biotech, and diagnostics, with named investments including Netramind Innovations (AI ophthalmic screening), Expora Therapeutics (BEV platform, UMD spinout), Duo Oncology, Humotech, MindTrace, WaveClear, and Reach Neuro.

Short descriptiontext

LifeX is a Pittsburgh-based life science accelerator and venture platform that runs a four-program continuum — Accelerator, Launchpad, Catalyst, and Ventures — to move early-stage healthcare startups from translational research through Series A funding. It serves founders across medical devices, biotech, pharma, and digital health, supported by a $2M EDA grant and regional ecosystem partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPittsburgh, United States
HQ citystring
Pittsburgh
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
life science accelerator, startup commercialization support, venture capital funding, biotech investment platform, healthcare startup programs
Industry2 codes
1Learning Experience Design (LXD) & UX for Learning
CodeEDAGAKAFPrimaryYes
2Learning Experience Platforms (LXP) & Learning Portals
CodeEDAFAAABPrimaryNo
NAICS code3 codes
  • Other Scientific and Technical Consulting Services54169
  • Portfolio Management and Investment Advice52394
  • Portfolio Management and Investment Advice523940
SIC code2 codes
  • Services-Management Consulting Services8742
  • Investment Advice6282
Product category
Life Science Startup Accelerator
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Accelerator Program
TypeProfessional Services
Description

The LifeX Accelerator is delivered at no charge for selected companies, requiring no fees or equity in return. This program is made possible through support from government grants (EDA) and foundation funding.

lifexglobal.com
2Launchpad Program
TypeSubscription Recurring
Description

Launchpad operates on a deliverable-based fee/equity compensation structure, providing customized project plans with fractional expert teams and milestone-driven support for startups approaching pilots or fundraising.

lifexglobal.com
3Ventures Investment Returns
TypeLicensing Royalties
Description

LifeX Ventures provides pre-seed through Series A funding and strategic guidance, generating returns through equity ownership in portfolio companies across medical devices, health-tech, biotech, pharmaceuticals, and digital health.

lifexglobal.com
4Government Grants
TypeManaged Services
Description

LifeX received a $2 million grant from the U.S. Department of Commerce's Economic Development Administration (EDA) Build to Scale Program to expand support for life sciences startups, focusing on acceleration, talent engagement, and industry leadership building.

prnewswire.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Pricing details4 tiers
1LifeX Accelerator - No cost program for selected early-stage life science startups
ModelFreemiumBilling cadenceMulti-year contract
Notes

The LifeX Accelerator program is delivered at no charge for selected companies, requiring no fees or equity in return. It is a three-month virtual program with no geographic restrictions.

lifexglobal.com
2Launchpad - Milestone-based fee/equity structure
ModelOutcome Based/ PerformanceBilling cadenceMulti-year contract
Notes

Launchpad delivers customized project plans, fractional expert team support, and milestone-driven execution. Fee structure is deliverable-based with equity component. Requires referral from Accelerator, Ventures, or investor/partner.

lifexglobal.com
3Catalyst - Embedded executive leadership connected to Ventures pipeline
ModelHybridBilling cadenceMulti-year contract
Notes

Catalyst embeds seasoned executives into startups to drive strategy and execution. Support is often a precursor to or integrated with LifeX Ventures funding. Connected to Ventures pipeline.

lifexglobal.com
4Ventures - Pre-seed through Series A investment
ModelTransaction based/ take rateBilling cadenceMulti-year contract
Notes

LifeX Ventures provides milestone-based capital deployment with structured due diligence and expert review. Investment in high-potential startups that have been pressure-tested across the LifeX Continuum.

lifexglobal.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 5 records shown
1LifeX Accelerator
Description

A three-month virtual program for high-potential life science and healthcare ventures to build pathway to investor readiness.

lifexglobal.com
+4 more records
Core offering1 text field

LifeX operates a continuum model that combines programmatic support, strategic investment, and hands-on execution to help early-stage life science startups navigate commercialization. Its core offerings are four integrated programs—Accelerator (three-month virtual cohort program with no fees or equity), Launchpad (milestone-driven strategic support), Catalyst (embedded executive leadership), and Ventures (pre-seed through Series A investment)—along with the LifeX Connect talent-matching program for university spinouts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 90% of life science startups fail due to gaps in funding, commercialization expertise, and market validation that LifeX addresses
+2 more records
Product overview1 text field

LifeX is a Pittsburgh-based life science startup accelerator and venture platform offering a unified continuum model with four integrated programs: the LifeX Accelerator (three-month virtual cohort program for early-stage startups to build investor readiness), LifeX Launchpad (customized strategic support with expert mentorship and milestone-driven execution), LifeX Catalyst (venture-building platform embedding seasoned executives into startups), and LifeX Ventures (investment arm providing pre-seed through Series A funding). LifeX Connect provides talent matching for embedded entrepreneurs at university spinouts. The platform integrates programmatic support, strategic investment, and a curated network of domain experts to help founders navigate from translational research through Series A funding.

Product and service1 record
1LifeX Accelerator
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-09-10
Description

PLSA leaders participated in a roundtable discussion with LifeX founders and Pennsylvania State Representative Arvind Venkat, MD. The collaboration strengthens the region's life sciences ecosystem through cross-institutional engagement and policy advocacy.

2Women in Bio Pittsburgh
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-10
Description

Women in Bio Pittsburgh leaders participated in the LifeX roundtable on medical innovation with Rep. Arvind Venkat. The partnership supports female leadership and advancement in the life sciences sector.

lifexglobal.com
3Pennsylvania State Representative Arvind Venkat, MD
Strategic tierMajorTypeOthersAnnounced on2025-09-10
Description

Rep. Arvind Venkat participated in a roundtable with LifeX founders and ecosystem partners to discuss medical innovation policy. His priorities include sustaining immigration for healthcare workforce, ensuring stable university research funding, and building coalitions for policy advocacy.

lifexglobal.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

LifeX engages with University of Pittsburgh for startup sourcing, research collaboration, and talent development. Notable spinouts include Netramind Innovations. LifeX provides internship opportunities for Pitt students.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

UPMC Enterprises (innovation and corporate VC arm of UPMC) contributed to investment diligence and rollout of IT solutions. LifeX team member Kelly Collier previously worked there, bringing healthcare innovation ecosystem expertise.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

University of Maryland is the source institution for Expora Therapeutics, a spinout that participated in LifeX Accelerator and Launchpad. The partnership demonstrates LifeX's reach beyond Pittsburgh for supporting university spinouts nationally.

7BEVbiotics, Inc.
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Expora Therapeutics entered into a long-term agreement to manufacture bacterial extracellular vesicles (BEVs) for BEVbiotics, Inc., an innovative consumer-focused startup in the probiotics supplement industry. Demonstrates LifeX's role in enabling industry partnerships.

lifexglobal.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

IndieBio is the largest life science accelerator globally, running cohort-based programs with equity investment. Direct comparable to LifeX Accelerator and Ventures arm, targeting biology-driven startups from formation through Series A.

TypeDirect peer
Description

BioGenerator is a St. Louis-based life science startup generator combining lab space, investment, and venture-building services. Closest geographic and structural peer to LifeX as a regional life science commercialization platform.

TypeDirect peer
Description

MBC BioLabs is a Bay Area life science incubator offering lab space, equipment, and venture support to early-stage startups. Direct comparable on the incubator/venture support axis serving pre-seed and seed life science companies.

TypeDirect peer
Description

CDL runs an objective-driven mentorship program for science-based startups including a Health & Life Sciences stream. Comparable to LifeX as a structured, cohort-style accelerator targeting ventures with breakthrough IP, and notably a Heart IO alumni connection to LifeX.

TypeDirect peer
Description

Petri is a Boston-area accelerator focused on emerging life science and biotech startups at the pre-seed stage. Direct peer in the life science accelerator category with a similar founder-support methodology.

TypeBroad incumbent
Description

Y Combinator runs the world's largest startup accelerator with a dedicated bio track. Serves as a broad incumbent that competes for life science founders with significantly stronger brand, network, and follow-on capital relationships.

TypeBroad incumbent
Description

Techstars operates multiple accelerators globally including healthcare and biotech-focused programs. Broad incumbent in the accelerator category competing for similar early-stage life science founders.

TypeRegional player
Description

Innovation Works is a Pittsburgh-based seed-stage investor and accelerator. Direct regional peer operating in the same Western PA ecosystem with overlapping portfolio companies and university relationships.

TypeBroad incumbent
Description

Flagship Pioneering is a life science venture studio that originates and builds biotech companies from breakthrough science. Comparable to LifeX Catalyst as a venture-building platform with embedded operating teams and equity ownership model.

TypeBroad incumbent
Description

ARCH is a leading early-stage venture capital firm focused on life sciences, physical sciences, and technology. Broad incumbent comparable to LifeX Ventures on the investment side, though operating at significantly larger fund sizes and later stages.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers24 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeX

Life Science Startup Acceleratorlifexglobal.com

LifeX is a Pittsburgh-based life science accelerator and venture platform that runs a four-program continuum — Accelerator, Launchpad, Catalyst, and Ventures — to move early-stage healthcare startups from translational research through Series A funding. It serves founders across medical devices, biotech, pharma, and digital health, supported by a $2M EDA grant and regional ecosystem partnerships.

What LifeX does

LifeX Global (operating as LifeX, and designated the Life Science Greenhouse for Western Pennsylvania by PA DCED) is a Pittsburgh-based, privately held life science startup support platform founded in 2017. It operates a four-program continuum — Accelerator, Launchpad, Catalyst, and Ventures — augmented by LifeX Connect for talent matching, designed to move early-stage life science ventures from translational research through Series A funding. The Accelerator is a three-month virtual cohort program offered at no cost and with no equity taken, structured around 25+ interactive sessions and a curated network of 70+ domain experts, investors, and mentors. Launchpad provides milestone-driven, customized project support for startups approaching pilots or fundraising, priced on a deliverable-based fee/equity structure. Catalyst embeds seasoned executives into portfolio companies to drive strategy and execution, typically feeding the Ventures investment pipeline. Ventures deploys pre-seed through Series A capital in medical devices, health-tech, biotech, pharmaceuticals, and digital health, targeting milestone-based inflection points.

LifeX's business model mixes non-dilutive capital (a $2M U.S. EDA Build to Scale grant awarded in November 2023, plus Hillman Foundation and PA DCED support), fee/equity compensation from Launchpad, and equity ownership in portfolio companies through Ventures. Go-to-market is sales-led and referral-driven: companies enter via direct application, university partnerships (University of Pittsburgh, Carnegie Mellon, University of Maryland), or ecosystem referrals (PLSA, Women in Bio Pittsburgh, UPMC Enterprises), then flow through the continuum via internal handoffs. The organization is headquartered at 218 Oakland Ave, Pittsburgh, with a stated 1-10 person core team and a much larger 70+ expert network, serving a national founder base through virtual cohorts with an in-person Pittsburgh bootcamp. Its portfolio spans digital health, therapeutics, medical devices, biotech, and diagnostics, with named investments including Netramind Innovations (AI ophthalmic screening), Expora Therapeutics (BEV platform, UMD spinout), Duo Oncology, Humotech, MindTrace, WaveClear, and Reach Neuro.

LifeX firmographics

Firmographics
Name
LifeX
Legal name
LifeX Global
Website
https://lifexglobal.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
11–50 employees
Short description
LifeX is a Pittsburgh-based life science accelerator and venture platform that runs a four-program continuum — Accelerator, Launchpad, Catalyst, and Ventures — to move early-stage healthcare startups from translational research through Series A funding. It serves founders across medical devices, biotech, pharma, and digital health, supported by a $2M EDA grant and regional ecosystem partnerships.
Ownership category
akta.pro rank

LifeX industry classification

Industry
Product category
Life Science Startup Accelerator
NAICS
Other Scientific and Technical Consulting Services (54169), Portfolio Management and Investment Advice (52394), Portfolio Management and Investment Advice (523940)
SIC
Services-Management Consulting Services (8742), Investment Advice (6282)
akta.pro primary industry
Learning Experience Design (LXD) & UX for Learning (EDAGAKAF)
akta.pro secondary industry
Learning Experience Platforms (LXP) & Learning Portals (EDAFAAAB)

Keywords

  • Life science accelerator
  • Startup commercialization support
  • Venture capital funding
  • Biotech investment platform
  • Healthcare startup programs

Where LifeX is headquartered

Location

Headquarters

HQ city
Pittsburgh
HQ country
United States
HQ region
North America

Offices1 record

Markets served

LifeX business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

  1. Accelerator Program: The LifeX Accelerator is delivered at no charge for selected companies, requiring no fees or equity in return. This program is made possible through support from government grants (EDA) and foundation funding.
  2. Launchpad Program: Launchpad operates on a deliverable-based fee/equity compensation structure, providing customized project plans with fractional expert teams and milestone-driven support for startups approaching pilots or fundraising.
  3. Ventures Investment Returns: LifeX Ventures provides pre-seed through Series A funding and strategic guidance, generating returns through equity ownership in portfolio companies across medical devices, health-tech, biotech, pharmaceuticals, and digital health.
  4. Government Grants: LifeX received a $2 million grant from the U.S. Department of Commerce's Economic Development Administration (EDA) Build to Scale Program to expand support for life sciences startups, focusing on acceleration, talent engagement, and industry leadership building.

Pricing tiers

ModelBillingPrice
FreemiumMulti-year contractLifeX Accelerator - No cost program for selected early-stage life science startups
Outcome Based/ PerformanceMulti-year contractLaunchpad - Milestone-based fee/equity structure
HybridMulti-year contractCatalyst - Embedded executive leadership connected to Ventures pipeline
Transaction based/ take rateMulti-year contractVentures - Pre-seed through Series A investment

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

LifeX product offering

Product offering

Core offering

LifeX operates a continuum model that combines programmatic support, strategic investment, and hands-on execution to help early-stage life science startups navigate commercialization. Its core offerings are four integrated programs—Accelerator (three-month virtual cohort program with no fees or equity), Launchpad (milestone-driven strategic support), Catalyst (embedded executive leadership), and Ventures (pre-seed through Series A investment)—along with the LifeX Connect talent-matching program for university spinouts.

Product overview

LifeX is a Pittsburgh-based life science startup accelerator and venture platform offering a unified continuum model with four integrated programs: the LifeX Accelerator (three-month virtual cohort program for early-stage startups to build investor readiness), LifeX Launchpad (customized strategic support with expert mentorship and milestone-driven execution), LifeX Catalyst (venture-building platform embedding seasoned executives into startups), and LifeX Ventures (investment arm providing pre-seed through Series A funding). LifeX Connect provides talent matching for embedded entrepreneurs at university spinouts. The platform integrates programmatic support, strategic investment, and a curated network of domain experts to help founders navigate from translational research through Series A funding.

Differentiator

Problem solved

Functional benefit

Brands

  • LifeX Accelerator: A three-month virtual program for high-potential life science and healthcare ventures to build pathway to investor readiness.
  • LifeX Launchpad
  • LifeX Catalyst
  • LifeX Ventures
  • LifeX Connect

Products and services

  • LifeX Accelerator

Quantifiable outcome

  • 90% of life science startups fail due to gaps in funding, commercialization expertise, and market validation that LifeX addresses
  • +2 more outcomes

Companies that use LifeX

Customer profile

Named customers24 records

Segments4 records

Ideal customer profiles2 records

LifeX technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature1 record

LifeX partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered major, minor and core.

  • Pittsburgh Life Sciences Alliance (PLSA)majorStrategic or Co-development Partner · 10 September 2025PLSA leaders participated in a roundtable discussion with LifeX founders and Pennsylvania State Representative Arvind Venkat, MD. The collaboration strengthens the region's life sciences ecosystem through cross-institutional engagement and policy advocacy.
  • Women in Bio PittsburghminorStrategic or Co-development Partner · 10 September 2025Women in Bio Pittsburgh leaders participated in the LifeX roundtable on medical innovation with Rep. Arvind Venkat. The partnership supports female leadership and advancement in the life sciences sector.
  • Pennsylvania State Representative Arvind Venkat, MDmajorOthers · 10 September 2025Rep. Arvind Venkat participated in a roundtable with LifeX founders and ecosystem partners to discuss medical innovation policy. His priorities include sustaining immigration for healthcare workforce, ensuring stable university research funding, and building coalitions for policy advocacy.
  • University of PittsburghcoreStrategic or Co-development PartnerLifeX engages with University of Pittsburgh for startup sourcing, research collaboration, and talent development. Notable spinouts include Netramind Innovations. LifeX provides internship opportunities for Pitt students.
  • UPMC EnterprisesmajorStrategic or Co-development PartnerUPMC Enterprises (innovation and corporate VC arm of UPMC) contributed to investment diligence and rollout of IT solutions. LifeX team member Kelly Collier previously worked there, bringing healthcare innovation ecosystem expertise.
  • University of MarylandcoreStrategic or Co-development PartnerUniversity of Maryland is the source institution for Expora Therapeutics, a spinout that participated in LifeX Accelerator and Launchpad. The partnership demonstrates LifeX's reach beyond Pittsburgh for supporting university spinouts nationally.
  • BEVbiotics, Inc.majorStrategic or Co-development PartnerExpora Therapeutics entered into a long-term agreement to manufacture bacterial extracellular vesicles (BEVs) for BEVbiotics, Inc., an innovative consumer-focused startup in the probiotics supplement industry. Demonstrates LifeX's role in enabling industry partnerships.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

LifeX competitors and assessment

Company assessment

Direct peers

  • IndieBio: IndieBio is the largest life science accelerator globally, running cohort-based programs with equity investment. Direct comparable to LifeX Accelerator and Ventures arm, targeting biology-driven startups from formation through Series A.
  • BioGenerator: BioGenerator is a St. Louis-based life science startup generator combining lab space, investment, and venture-building services. Closest geographic and structural peer to LifeX as a regional life science commercialization platform.
  • MBC BioLabs: MBC BioLabs is a Bay Area life science incubator offering lab space, equipment, and venture support to early-stage startups. Direct comparable on the incubator/venture support axis serving pre-seed and seed life science companies.
  • Creative Destruction Lab: CDL runs an objective-driven mentorship program for science-based startups including a Health & Life Sciences stream. Comparable to LifeX as a structured, cohort-style accelerator targeting ventures with breakthrough IP, and notably a Heart IO alumni connection to LifeX.
  • Petri (Bioluminescent): Petri is a Boston-area accelerator focused on emerging life science and biotech startups at the pre-seed stage. Direct peer in the life science accelerator category with a similar founder-support methodology.

Broad incumbents

  • Y Combinator: Y Combinator runs the world's largest startup accelerator with a dedicated bio track. Serves as a broad incumbent that competes for life science founders with significantly stronger brand, network, and follow-on capital relationships.
  • Techstars: Techstars operates multiple accelerators globally including healthcare and biotech-focused programs. Broad incumbent in the accelerator category competing for similar early-stage life science founders.
  • Flagship Pioneering: Flagship Pioneering is a life science venture studio that originates and builds biotech companies from breakthrough science. Comparable to LifeX Catalyst as a venture-building platform with embedded operating teams and equity ownership model.
  • ARCH Venture Partners: ARCH is a leading early-stage venture capital firm focused on life sciences, physical sciences, and technology. Broad incumbent comparable to LifeX Ventures on the investment side, though operating at significantly larger fund sizes and later stages.

Regional players

  • Innovation Works: Innovation Works is a Pittsburgh-based seed-stage investor and accelerator. Direct regional peer operating in the same Western PA ecosystem with overlapping portfolio companies and university relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

LifeX social profiles

Digital presence

LifeX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeX leadership team

Management profile

Number of profiles

Profiles7 records

LifeX funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeX M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeX

What does LifeX do?

LifeX operates a continuum model that combines programmatic support, strategic investment, and hands-on execution to help early-stage life science startups navigate commercialization. Its core offerings are four integrated programs—Accelerator (three-month virtual cohort program with no fees or equity), Launchpad (milestone-driven strategic support), Catalyst (embedded executive leadership), and Ventures (pre-seed through Series A investment)—along with the LifeX Connect talent-matching program for university spinouts.

Is LifeX a public or private company?

LifeX is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was LifeX founded?

LifeX was founded in 2017. It employs 11 to 50 people.

Where is LifeX based?

LifeX is headquartered in Pittsburgh, United States, in the North America region.

How does LifeX make money?

Four revenue lines are on record. Accelerator Program is the primary driver. The others are launchpad Program, ventures Investment Returns and government Grants.

Who are LifeX's main competitors?

Direct peers on record are IndieBio, BioGenerator, MBC BioLabs, Creative Destruction Lab and Petri (Bioluminescent). Broad incumbents are Y Combinator, Techstars, Flagship Pioneering and ARCH Venture Partners. Innovation Works is listed as a regional player.

Does LifeX have an API?

No public API is recorded for LifeX.

What industry is LifeX in?

LifeX's product category is Life Science Startup Accelerator. Its primary akta.pro industry code is EDAGAKAF, Learning Experience Design (LXD) & UX for Learning, with a secondary code of EDAFAAAB, Learning Experience Platforms (LXP) & Learning Portals. Its NAICS code is 54169 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
StartuptodayLifeX partners with Flitto... to intensify the construction of a healthcare AI multimodal dataset.LifeX and Flitto signed an MOU to build a healthcare AI multimodal dataset integrating text, image, and video. They will use data from LifeX's MommyTalk and Rarenote services, apply de-identification, and support multilingual construction in Korean, English, Vietnamese, and Indonesian.스타트업엔(StartupN)LifeX and Flitto, jointly building a high-quality healthcare dataset for AI learning.LifeX and Flitto are collaborating to build a high-quality healthcare dataset for AI learning, emphasizing data review and personal information protection. The partnership aims to create data assets usable in medical AI research and service development.TechStartupsIlant Health raises $15M to use AI for obesity care as employers rethink costly GLP-1 coverageIlant Health raised $15 million in Series A funding led by Cornucopian Capital, bringing total funding to over $22 million. The New York-based startup uses AI to help employers manage obesity care costs, claiming members achieve an average 15% weight loss. The company is working with Eli Lilly and Novo Nordisk.FinSMEsIlant Health Raises $15M in Series A FundingIlant Health, a New York City-based AI-supported precision obesity and cardiometabolic care platform, raised $15M in Series A funding led by Cornucopian Capital. The company, which has raised $22M total, will use the funds to expand value-based care infrastructure and accelerate commercial deployment with large employer groups and managed care plans.스타트업엔(StartupN)"I also look at children's language development through AI"... LifeX collaborates with a language pathology research institute.LifeX signed an MOU with the Im Dong-seon AI Language Research Institute to develop an AI-based child language development analysis system. The collaboration combines MamiTalk's 2 million user data with language pathology expertise. LifeX plans to expand beyond pregnancy and childbirth into overall infant development.LinkedInThiopoly is pleased to announce the kickoff of the company’s pre-seed funding with commitments from LifeX and Innovation Works, two leading early stage investors in the Pittsburgh region. Pre-seed…Thiopoly has initiated its pre-seed funding round with commitments from LifeX and Innovation Works, which are prominent early-stage investors in Pittsburgh. The funding will help Thiopoly advance its pilot phase and enhance its core technology for market introduction, pending due diligence. This collaboration aims to address the digital visibility challenges in pharmacy and healthcare.PR NewswireLifeX is awarded $2 million grant through federal EDA's Build to Scale ProgramLifeX has been awarded a $2 million grant from the U.S. Department of Commerce's Economic Development Administration through its Build to Scale Program. The funding is designated to accelerate technology entrepreneurship by scaling LifeX's accelerator and commercialization programs for life science startups in Pittsburgh and beyond.NewswiseLifeX is awarded a $2 million grant through federal EDA's Build to Scale ProgramLifeX was awarded a $2 million grant from the U.S. Department of Commerce’s Economic Development Administration through its Build to Scale program on November 15. The funding will be used to expand LifeX's accelerator and commercialization programs, nurture the life science entrepreneurship ecosystem in Pittsburgh, and attract talent to support local startups.PR NewswireLifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr PharmaceuticalLifeX announced that its portfolio company NeuBase Therapeutics has entered into a definitive merger agreement with Ohr Pharmaceutical, creating a public company to be listed on NASDAQ. The combined entity will be led by Dietrich A. Stephan, former CEO of LifeX, and will focus on advancing NeuBase's peptide-nucleic acid antisense oligonucleotide technology platform for developing therapies targeting severe genetic diseases. This merger validates LifeX's accelerator model of translating life sciences innovation from research to marketplace within under a year.PR NewswireGeneNews Announces Q2 2018 Results and Provides Progress UpdateGeneNews Limited reported Q2 2018 results showing a consolidated net loss of $3.2 million for the six-month period ended June 30, 2018, compared to a $2.0 million loss in the same period in 2017. The company closed on C$3.2 million in financing through a Unit private placement and Lind convertible security to support its four primary growth area initiatives. GeneNews also announced a partnership with LifeX to expand adoption of its liquid biopsy diagnostics and to develop its Aristotle platform for early detection of ten cancers from a single blood sample, with Q3 test volume reportedly up 40% over previous months.